United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-3375_1ce8f03a-6918-908c-e063-6394a90a270c
- Product NDC
- 68071-3375
- Form
- TABLET, FILM COATED
- Composition / generic term
- spironolactone
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170711
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE (68071-3375-1) · 68071-3375-1
- 30 TABLET, FILM COATED in 1 BOTTLE (68071-3375-3) · 68071-3375-3
- 60 TABLET, FILM COATED in 1 BOTTLE (68071-3375-6) · 68071-3375-6
- 180 TABLET, FILM COATED in 1 BOTTLE (68071-3375-8) · 68071-3375-8
- 90 TABLET, FILM COATED in 1 BOTTLE (68071-3375-9) · 68071-3375-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →